tiprankstipranks
Advertisement
Advertisement

AU:ALA Stock Latest News

Arovella Appoints New Director With No Current Shareholdings
Company AnnouncementsArovella Appoints New Director With No Current Shareholdings
2d ago
Arovella boosts board with four senior biotech and finance appointments
PremiumCompany Announcements
Arovella boosts board with four senior biotech and finance appointments
5d ago
Arovella shareholder withdraws invalid requisition, easing governance overhang
PremiumCompany Announcements
Arovella shareholder withdraws invalid requisition, easing governance overhang
10d ago
Arovella Rejects Shareholder Board Requisition as Invalid
PremiumCompany Announcements
Arovella Rejects Shareholder Board Requisition as Invalid
11d ago
Arovella Showcases CLDN18.2 CAR-iNKT Solid Tumour Data at AACR
PremiumCompany Announcements
Arovella Showcases CLDN18.2 CAR-iNKT Solid Tumour Data at AACR
13d ago
Arovella Boosts Cash Reserves with Additional R&D Tax Rebate
PremiumCompany AnnouncementsArovella Boosts Cash Reserves with Additional R&D Tax Rebate
18d ago
Arovella Options Lapse, Simplifying Capital Structure
Premium
Company Announcements
Arovella Options Lapse, Simplifying Capital Structure
20d ago
Arovella Therapeutics Seeks ASX Quotation for 1.6 Million New Shares
Premium
Company Announcements
Arovella Therapeutics Seeks ASX Quotation for 1.6 Million New Shares
23d ago
Arovella issues 1.6m new shares and affirms regulatory compliance
PremiumCompany Announcements
Arovella issues 1.6m new shares and affirms regulatory compliance
23d ago
Arovella Weighs Validity of Requisitioned Meeting for Board Appointments
PremiumCompany Announcements
Arovella Weighs Validity of Requisitioned Meeting for Board Appointments
23d ago
Arovella’s ALA-101 Trial Moves Toward Launch In CD19 Blood Cancers
PremiumCompany Announcements
Arovella’s ALA-101 Trial Moves Toward Launch In CD19 Blood Cancers
24d ago
ALA
Arovella’s Armoured CLDN18.2 CAR-iNKT Cells Show Strong Activity Against Gastric and Pancreatic Cancer In Vitro
PremiumCompany Announcements
Arovella’s Armoured CLDN18.2 CAR-iNKT Cells Show Strong Activity Against Gastric and Pancreatic Cancer In Vitro
1M ago
Arovella Wins TGA Green Light to Run ALA-101 Cell Therapy Trial Under Streamlined CTN Pathway
PremiumCompany AnnouncementsArovella Wins TGA Green Light to Run ALA-101 Cell Therapy Trial Under Streamlined CTN Pathway
2M ago
Arovella Therapeutics Announces Departure of Director Gary Phillips
Premium
Company Announcements
Arovella Therapeutics Announces Departure of Director Gary Phillips
3M ago
Arovella reshapes board as CAR-iNKT cell therapy program advances
Premium
Company Announcements
Arovella reshapes board as CAR-iNKT cell therapy program advances
3M ago
Arovella Steps Up Investor Outreach With Euroz Hartleys Forum and Roadshow
PremiumCompany Announcements
Arovella Steps Up Investor Outreach With Euroz Hartleys Forum and Roadshow
3M ago
Arovella Wins FDA IND Clearance as It Enters Clinical Stage With CAR-iNKT Cancer Therapy
PremiumCompany Announcements
Arovella Wins FDA IND Clearance as It Enters Clinical Stage With CAR-iNKT Cancer Therapy
3M ago
Arovella Wins FDA IND Clearance for Lead Cell Therapy ALA-101
PremiumCompany Announcements
Arovella Wins FDA IND Clearance for Lead Cell Therapy ALA-101
3M ago
Arovella Files IND for Lead CAR-iNKT Therapy as Cash Reserves Back 2026 Clinical Push
PremiumCompany Announcements
Arovella Files IND for Lead CAR-iNKT Therapy as Cash Reserves Back 2026 Clinical Push
3M ago
Arovella Therapeutics Names New Company Secretary and CFO to Support Growth
PremiumCompany AnnouncementsArovella Therapeutics Names New Company Secretary and CFO to Support Growth
3M ago
Arovella to Release 936,303 Escrowed Shares Issued for Investor Relations Services
Premium
Company Announcements
Arovella to Release 936,303 Escrowed Shares Issued for Investor Relations Services
4M ago
Arovella Seeks FDA Green Light for First-in-Human Trial of Lead CAR-iNKT Therapy
Premium
Company Announcements
Arovella Seeks FDA Green Light for First-in-Human Trial of Lead CAR-iNKT Therapy
4M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >